Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Monotherapy

NCT00442312 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma

Interventions

DRUG: Combigan Ophthalmic Solutiom

Sponsor

Genovate Biotechnology Co., Ltd.,

Collaborators

[object Object]